Data |
Descrição |
Vacina |
Quantidade 1° dose |
Quantidade 2° dose |
Quantidade 1° dose extra |
Quantidade 2° dose extra |
Quantidade de doses indigena |
Total |
09/08/2021 |
VACINA CONTRA SARS-COV2 |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
300 |
0 |
0 |
0 |
0 |
300 |
09/08/2021 |
VACINA CONTRA SARS-COV2 - 05 DOSES |
Janssen Covid-19 Vaccine |
15 |
0 |
0 |
0 |
0 |
15 |
09/08/2021 |
VACINA CONTRA SARS-COV2 - 05 DOSES |
Fiocruz/Oxford/AstraZeneca |
190 |
5 |
0 |
0 |
0 |
195 |
09/08/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
40 |
0 |
0 |
0 |
0 |
40 |
11/08/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
288 |
0 |
0 |
0 |
0 |
288 |
11/08/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
50 |
200 |
0 |
0 |
0 |
250 |
13/08/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
90 |
0 |
0 |
0 |
0 |
90 |
16/08/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
180 |
0 |
0 |
0 |
0 |
180 |
16/08/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
110 |
0 |
0 |
0 |
0 |
110 |
19/08/2021 |
VACINA CONTRA SARS-COV2 - 05 DOSES |
Fiocruz/Oxford/AstraZeneca |
0 |
155 |
0 |
0 |
0 |
155 |
19/08/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
90 |
200 |
0 |
0 |
0 |
290 |
20/08/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
300 |
0 |
0 |
0 |
0 |
300 |
20/08/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
168 |
0 |
0 |
0 |
0 |
168 |
23/08/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
180 |
40 |
0 |
0 |
0 |
220 |
24/08/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
288 |
0 |
0 |
0 |
0 |
288 |
24/08/2021 |
VACINA CONTRA SARS-COV2 - 05 DOSES |
Fiocruz/Oxford/AstraZeneca |
0 |
295 |
0 |
20 |
0 |
315 |
24/08/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
80 |
50 |
0 |
0 |
0 |
130 |
26/08/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
156 |
0 |
0 |
0 |
0 |
156 |
31/08/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
54 |
300 |
0 |
0 |
0 |
354 |
31/08/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
160 |
110 |
0 |
0 |
0 |
270 |
03/09/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
380 |
90 |
0 |
0 |
0 |
470 |
06/09/2021 |
VACINA CONTRA SARS-COV2 - 05 DOSES |
Fiocruz/Oxford/AstraZeneca |
0 |
305 |
0 |
0 |
0 |
305 |
06/09/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
0 |
108 |
0 |
0 |
0 |
108 |
09/09/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
150 |
0 |
0 |
0 |
0 |
150 |
13/09/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
210 |
84 |
0 |
0 |
0 |
294 |
13/09/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
70 |
260 |
0 |
0 |
0 |
330 |
16/09/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
180 |
0 |
0 |
0 |
0 |
180 |
16/09/2021 |
VACINA CONTRA SARS-COV2 - 10 DOSES |
Butantan/CoronaVac |
0 |
160 |
0 |
0 |
0 |
160 |
17/09/2021 |
VACINA CONTRA SARS-COV2 - 06 DOSES |
BNT162b2 - BioNTech/Fosun Pharma/Pfizer |
269 |
120 |
0 |
0 |
0 |
461 |
21/09/2021 |
VACINA CONTRA SARS-COV2 - 05 DOSES |
Fiocruz/Oxford/AstraZeneca |
0 |
75 |
0 |
0 |
0 |
75 |